Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy

C Cyrille Touzeau R Roberto Mina (Division of Hematology, Department of Molecular Biotechnology and Health Sciences, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy) H Hang Quach (University of Melbourne, St. Vincent’s Hospital Melbourne, Melbourne, VIC, Australia) V Vania Hungria (Clinica São Germano, São Paulo) D Divaya Bhutani (Columbia University Medical Center, New York) W Wenming Chen (Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing) S Swarup Kumar (Division of Hematology and Oncology, Neag Comprehensive Cancer Center, UConn Health, Farmington, CT) C Chakra Chaulagain (Department of Hematology and Oncology, Myeloma and Amyloidosis Program, Cleveland Clinic Florida, Weston) M Meletios Athanasios Dimopoulos (Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens) N Nizar J. Bahlis (Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada) S Senem Maral (Department of Hematology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey) N Niels W.C.J. van de Donk (Department of Hematology, Amsterdam University Medical Center, Cancer Center Amsterdam Vrije Universiteit Amsterdam, Amsterdam) J Jayr Schmidt Filho (Department of Hematology, A.C. Camargo Cancer Center, São Paulo) K Khalid Saja (Hematology Department, Colchester Hospital, East Suffolk and North Essex NHS Foundation Trust, Colchester, United Kingdom) R Raphael Teipel (Department of Internal Medicine I, University Hospital Dresden, Technical University Dresden, Dresden, Germany) M Miki Ando (Department of Hematology, Juntendo University School of Medicine, Tokyo) W Wilfried Roeloffzen (Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands) O Ombretta Annibali (Policlinico Universitario Campus Bio-Medico, Dipartimento di Medicina e Chirurgia Università Campus Bio-Medico, Rome) B Bradley Augustson (Department of Hematology, Sir Charles Gairdner Hospital, Perth, WA, Australia) C Cirino Botta (Hematology Unit, “P. Giaccone” University Hospital and Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy) M Michel Delforge E Emmanuelle Bourgeois (Groupement des Hôpitaux de l’Institut Catholique de Lille, Lille, France) G Gabriele Buda (Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy) M Marek Hus A Aurore Perrot M Meir Preis (Institute of Hematology, Lady Davis Carmel Medical Center, Haifa, Israel) M Meral Beksac L Ludek Pour (Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic) S Sarah Farmer (Department of Hematology, Vejle Hospital, Vejle, Denmark) M Marta Nunes (Department of Hematology, Unidade Local de Saúde de Gaia e Espinho, Vila Nova de Gaia, Portugal) A Albert Oriol (Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Spain) T Thomas Melchardt (Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology, and Rheumatology, Cancer Research Laboratory of the Department of Internal Medicine III, Paracelsus Medical University, Salzburg, Austria) Y Yu Hu M Max Flogegård (Department of Internal Medicine, Falun General Hospital, Falun, Sweden) D Dai Wang (State Key Laboratory of Vaccines for Infectious Diseases, Xiang-An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University) L Lixia Pei (Johnson & Johnson, Raritan, NJ) S Susan Wroblewski (Johnson & Johnson, Spring House, PA) I Ingrid M. Ariës (Johnson & Johnson, Leiden, the Netherlands) N Natalia A. Quijano Cardé (Johnson & Johnson, Spring House, PA) T Tatiana Perova (Johnson & Johnson, Spring House, PA) T Tertia de Jager (Johnson & Johnson, Neuss, Germany) T Tzu-Min Yeh (Johnson & Johnson, Raritan, NJ) V Veronique Vanquickelberghe (Johnson & Johnson, Beerse, Belgium) P Priya Shah (Johnson & Johnson, High Wycombe, United Kingdom) K Katherine Chastain (Johnson & Johnson, Raritan, NJ) R Rachel Kobos (Johnson & Johnson, Raritan, NJ) R Robin Carson (Johnson & Johnson, Spring House, PA) O Ola Landgren

Article Details

Volume / Issue Vol. 395, Issue 5
Published July 30, 2026
Pages 440-453
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (48)

C

Cyrille Touzeau

R

Roberto Mina

Division of Hematology, Department of Molecular Biotechnology and Health Sciences, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy

H

Hang Quach

University of Melbourne, St. Vincent’s Hospital Melbourne, Melbourne, VIC, Australia

V

Vania Hungria

Clinica São Germano, São Paulo

D

Divaya Bhutani

Columbia University Medical Center, New York

W

Wenming Chen

Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing

S

Swarup Kumar

Division of Hematology and Oncology, Neag Comprehensive Cancer Center, UConn Health, Farmington, CT

C

Chakra Chaulagain

Department of Hematology and Oncology, Myeloma and Amyloidosis Program, Cleveland Clinic Florida, Weston

M

Meletios Athanasios Dimopoulos

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens

N

Nizar J. Bahlis

Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada

S

Senem Maral

Department of Hematology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey

N

Niels W.C.J. van de Donk

Department of Hematology, Amsterdam University Medical Center, Cancer Center Amsterdam Vrije Universiteit Amsterdam, Amsterdam

J

Jayr Schmidt Filho

Department of Hematology, A.C. Camargo Cancer Center, São Paulo

K

Khalid Saja

Hematology Department, Colchester Hospital, East Suffolk and North Essex NHS Foundation Trust, Colchester, United Kingdom

R

Raphael Teipel

Department of Internal Medicine I, University Hospital Dresden, Technical University Dresden, Dresden, Germany

M

Miki Ando

Department of Hematology, Juntendo University School of Medicine, Tokyo

W

Wilfried Roeloffzen

Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands

O

Ombretta Annibali

Policlinico Universitario Campus Bio-Medico, Dipartimento di Medicina e Chirurgia Università Campus Bio-Medico, Rome

B

Bradley Augustson

Department of Hematology, Sir Charles Gairdner Hospital, Perth, WA, Australia

C

Cirino Botta

Hematology Unit, “P. Giaccone” University Hospital and Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy

M

Michel Delforge

E

Emmanuelle Bourgeois

Groupement des Hôpitaux de l’Institut Catholique de Lille, Lille, France

G

Gabriele Buda

Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy

M

Marek Hus

A

Aurore Perrot

M

Meir Preis

Institute of Hematology, Lady Davis Carmel Medical Center, Haifa, Israel

M

Meral Beksac

L

Ludek Pour

Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic

S

Sarah Farmer

Department of Hematology, Vejle Hospital, Vejle, Denmark

M

Marta Nunes

Department of Hematology, Unidade Local de Saúde de Gaia e Espinho, Vila Nova de Gaia, Portugal

A

Albert Oriol

Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Spain

T

Thomas Melchardt

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology, and Rheumatology, Cancer Research Laboratory of the Department of Internal Medicine III, Paracelsus Medical University, Salzburg, Austria

Y

Yu Hu

M

Max Flogegård

Department of Internal Medicine, Falun General Hospital, Falun, Sweden

D

Dai Wang

State Key Laboratory of Vaccines for Infectious Diseases, Xiang-An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University

L

Lixia Pei

Johnson & Johnson, Raritan, NJ

S

Susan Wroblewski

Johnson & Johnson, Spring House, PA

I

Ingrid M. Ariës

Johnson & Johnson, Leiden, the Netherlands

N

Natalia A. Quijano Cardé

Johnson & Johnson, Spring House, PA

T

Tatiana Perova

Johnson & Johnson, Spring House, PA

T

Tertia de Jager

Johnson & Johnson, Neuss, Germany

T

Tzu-Min Yeh

Johnson & Johnson, Raritan, NJ

V

Veronique Vanquickelberghe

Johnson & Johnson, Beerse, Belgium

P

Priya Shah

Johnson & Johnson, High Wycombe, United Kingdom

K

Katherine Chastain

Johnson & Johnson, Raritan, NJ

R

Rachel Kobos

Johnson & Johnson, Raritan, NJ

R

Robin Carson

Johnson & Johnson, Spring House, PA

O

Ola Landgren